DETECTIVE: detection of endpoints and biomarkers for repeated dose toxicity testing using in vitro systems. Towards the replacement of in vivo repeated dose systemic toxicity testing.

Robim Marcelino Rodrigues, S. Bremer-Hoffmann, Joery De Kock, Sylvia Escher, Jan Hengstler, Paul Jennings, Hector Keun, Jos Kleinjans, Kolde Raivo, Annette Kopp Schneider, Ringwald Annette, Vera Rogiers, Agapios Sachinidis, Sickmann Albert, Dimitry Spitkovsky, Tamara Vanhaecke, Mathieu Vinken, Bob Van De Water, Jurgen Hescheler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

As one of the building blocks of the SEURAT-1 Research Initiative, the DETECTIVE project
focuses on a key element on which in vitro toxicity testing relies: the development of robust
and reliable, sensitive and specific in vitro biomarkers and surrogate endpoints that can be
used for safety assessments of chronically acting toxicants relevant for humans.
Original languageEnglish
Title of host publicationTowards the Replacement of in vivo Repeated Dose Systemic Toxicity Testing
PublisherMouzet Imprimerie
Pages166-185
Number of pages20
Volume4
ISBN (Print)978-2-9539634-3-4
Publication statusPublished - 2014

Keywords

  • SEURAT-1
  • DETECTIVE

Fingerprint

Dive into the research topics of 'DETECTIVE: detection of endpoints and biomarkers for repeated dose toxicity testing using in vitro systems. Towards the replacement of in vivo repeated dose systemic toxicity testing.'. Together they form a unique fingerprint.

Cite this